Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats

Journal of Hypertension

Volumn 16, Issue 12, 1998, Pages 1759-1765

  Teisman, Ard C H ^a   Pinto, Yigal M ^a   Buikema, Hendrik ^a   Flesch, Markus ^b   Böhm, Michael ^b   Paul, Martin ^c   Van Gilst, Wiek H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF COLOGNE   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Carvedilol; End organ damage; Hydralazine; Hypertension; Losartan; Quinapril; REN 2 rats

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE; HYDRALAZINE; LOSARTAN; MESSENGER RNA; NORADRENALIN; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM;

EID: 0031767781     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816120-00008     Document Type: Article

References (22)

1. Cutler JA. High blood pressure and end-organ damage. J Hypertens 1996; 14 (suppl 6):S3-S6.
2. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 1998; 39: 77-88.
3. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse REN-2 gene. Nature 1990; 344:541-544.
4. Lee MA, Böhm M, Kim S, Bachmann S, Bachmann J, Bader M, et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 1995; 25:570-580.
5. Hilgers KF, Peters J, Veelken R, Sommer M, Rupprecht G, Ganten D, et al. Increased vascular angiotensin formation in female rats harboring the mouse REN-2 gene. Hypertension 1992; 19:687-691.
6. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79:1-6.
7. Tio RA, Van Gilst WH, Rett K, Wolters K, Dietze GJ, Wesseling H. The effects of bradykinin and the ischemic isolated rat heart. Horm Metab Res Suppl 1990; 22:85-89.
8. Starke K. Presynaptic receptors. Annu Rev Pharmacol Toxicol 1981; 21:7-30.
9. Hashimoto H, Kanda A, Hubo H, Tanaka M. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia. J Cardiovasc Pharmacol 1997; 18 (suppl 4):S22-S28.
10. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Böhm M, et al. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 1992; 19:681-686.
11. Arvola P, Ruskoaho H, Wuorela H, Pekki A, Vapaatalo H, Pörsti I. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol 1993; 108:980-990.
12. Pinto YM, Buikema H, Van Gilst WH, Scholtens E, van Geel P, De Graeff PA, et al. Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J Mol Med 1997; 75:371-377.
13. Van Gilst WH, De Graeff PA, De Leeuw MJ, Scholtens E, Wesseling H. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exogenous and endogenous nitrovasodilators. J Cardiovasc Pharmacol 1991; 18:429-436.
14. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, Van Gilst WH. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17:787-794.
15. Westerink BHC. Analysis of trace amounts of catecholamines and related compounds in brain tissue, a study near the detection limit of liquid chromatography with electrochemical detection. J Chromatogr 1983; 6:2337-2351.
16. Ohta K, Kim S, Wanibuchi H, Ganten D, Iwao H. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR(mRen2)27 transgenic rats. Circulation 1996; 94:785-791.
17. Zarain-Herzberg A, Rupp H, Elimban V, Dhalla NS. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J 1996; 10:1303-1309.
18. 1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease? Eur Heart J 1998; 19 (suppl G):G13-G17.
19. Pinto YM, Tian X, Costerousse O, Stula M. Cardiac overexpression of angiotensin-converting enzyme in transgenic rats augments cardiac hypertophy [abstract]. Circulation 1997; 96 (suppl I):I629.
20. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 1996; 17:24-29.
21. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increased vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-1923.
22. Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension 1990; 16:107-120.